Format

Send to

Choose Destination
Liver Transpl. 2014 May;20(5):514-27. doi: 10.1002/lt.23826. Epub 2014 Feb 25.

Antibody-mediated rejection in liver transplantation: current controversies and future directions.

Author information

1
William J. von Liebig Transplantation Center, Mayo Clinic, Rochester, MN.

Abstract

Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.

PMID:
24470340
DOI:
10.1002/lt.23826
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center